Elevate Capital — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Seattle, US
Jonathan Belfort(Executive Officer)Sean Zhong(Executive Officer)Andy Troxel(Executive Officer)
BoardRobert Pflieger(Director)Steven Sperry(Director)
Board seatNitin Rai· per SEC Form D · $1M raise · filed May 2026
Phosio develops UV-curable metal oxide precursors that enable low-temperature deposition for optical and electronic components used in smart glasses, semiconductors, and display technologies.
Advanced ManufacturingHardwareNew MaterialsSemiconductorsCorvallis, US
Omid Sadeghi(Chief Executive Officer)
BoardBryn Pilney(Director)inAndrew Greenville(Director)Joe O'Keeffe(Director)
Co-investorsMESHSilicon CatalystTEL Venture Capital, Inc.
Trace Biosciences develops targeted fluorescent imaging agents, called Nerve Trace, that highlight nerves in real time during surgery so surgeons and surgical robots can avoid nerve damage.
BiotechHealthtechMedical DevicesBeaverton, US
Connor Barth(Executive Officer, Director)Summer Gibbs(Executive Officer, Director)Lei Wang(Executive Officer, Director)Jonathan Sorger(Director)
Co-investorsSciFounders
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.